Zymeworks任命Kristin Stafford为首席财务官

2026-04-01 18:17

Zymeworks (ZYME) has appointed Kristin Stafford as chief financial officer, effective April 1, 2026. Stafford recently served as senior vice president, chief accounting officer for Royalty Pharma.

More on Zymeworks

Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside
Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript
Zymeworks Inc. 2025 Q4 - Results - Earnings Call Presentation
Zymeworks outlines $1.5B milestone potential and signals milestone-driven expansion strategy through 2028
Zymeworks GAAP EPS of -$0.55 misses by $0.21, revenue of $2.52M misses by $18.01M